Retinopathy of Prematurity – ROP, is a vascular proliferative disease only present in premature newborns. The absence of vessels in the premature retina, leads to retinal ischemia (lack of blood supply/oxygen) which triggers vascular endothelia growth factor (VEGF). This is a signalling protein that promotes neovascularization (the growth of new blood vessels). However, these abnormal blood vessels can bleed, creating vision-impairing hemorrhages, scar tissue, and separation of the retina from the back of the eye (retinal detachment), which could lead to blindness.
Retinopathy of Prematurity (ROP)
Ophthalmologist, University of Sao Paulo
ROP is a potentially blinding disease in premature infants. A comprehensive knowledge of the disease, such as guidelines for screening, risk factors and treatment options helps aid in preventing the disease to progress to visual impairment and/or blindness in these infants.
At the end of the presentation, the clinician will be able to:
• Understand what is ROP
• Understand screening guidelines for ROP
• Understand risk factors for ROP
• Understand the zones and stage of ROP
• Understand treatment options for ROP
|Module 1||Retinopathy of Prematurity (ROP)|
|Unit 1||Retinopathy of Prematurity (ROP) - Video Lecture|
|Unit 2||Retinopathy of Prematurity (ROP) - The Quiz|